 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Stenhouse Mark
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-04-02 Sale | 2019-04-04 4:24 pm | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 11,192 | $92.54 | $1,035,697 | 14,308 (Indirect Direct) | View |
| 2020-02-26 Sale | 2020-02-28 4:39 pm | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 1,051 | $80.27 | $84,364 | 16,519 (Indirect Direct) | View |
| 2020-04-02 Sale | 2020-04-06 4:41 pm | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 11,948 | $56.69 | $677,332 | 29,571 (Indirect Direct) | View |
| 2021-03-16 Purchase | 2021-03-16 9:49 pm | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark COO | 14,000 | $19 | $266,000 | 14,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-04-02 Option Award | 2018-04-03 4:58 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-02-26 Option Award | 2019-02-28 8:22 pm | 2020-02-26 2029-02-26 | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 10,786 | $0 | 10,786 (Direct) | View |
| 2019-02-26 Option Award | 2019-02-28 8:22 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 13,051 | $0 | 13,051 (Direct) | View |
| 2019-04-02 Exercise | 2019-04-04 4:24 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 25,000 | $0 | 25,500 (Direct) | View |
| 2019-04-02 Exercise | 2019-04-04 4:24 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 25,000 | $0 | 50,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-18 4:40 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 14,123 | $0 | 14,123 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-18 4:40 pm | 2021-02-14 2030-02-14 | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 11,445 | $0 | 11,445 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 4:39 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 3,262 | $0 | 17,570 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 4:39 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 3,262 | $0 | 9,789 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 4:34 pm | N/A 2030-03-16 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-04-02 Exercise | 2020-04-06 4:41 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 25,000 | $0 | 41,519 (Direct) | View |
| 2020-04-02 Exercise | 2020-04-06 4:41 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Stenhouse Mark COO | 25,000 | $0 | 25,000 (Direct) | View |